Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

Orthobiologic Products

Open
2140910State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

SUNY Downstate Health Sciences University is seeking a not to exceed three year agreement for the procurement of orthobiologic products, specifically specialized human tissue grafts and bone substitutes. This procurement is being conducted under New York State Finance Law, section 163(3)(vi), utilizing Vizient Consortia Contract #MS9985. The required deliverables include formable cellular bone matrix, allograft cortical cancellous cellular matrix, osteochondral ankle talus, triple strand frozen graftlink, and various bone substitute dowels. The solicitation, numbered 2140910, is open to vendors who can demonstrate that their consumables are equivalent, compatible, and interchangeable with existing equipment and supplies. LifeNet Health is identified as a business enterprise that has been awarded a similar contract within the past five years. There are no set-aside requirements for this procurement, and goals for SDVOB, MBE, WBE, and DBE are all set at 0.00%. Interested parties should contact Carlos Villegas in the Purchasing Department for further discussion.

General Info

SUNY Downstate seeks a three-year agreement for orthobiologic products and bone substitutes.

Place of Performance

450 Clarkson Avenue, Brooklyn NY 11203, NY, USA

Set-Aside

NONE

Documents

2
PDF, High priority: read this firstspecifications
High
PDF, High priority: read this firstrfp
High

Read all 2 documents

Due in 17 days

Every page of every file, in your free workspace.

Read the documents

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

View Full Breakdown
Due in 17 days

Everything you need to bid on this one

Open the full contract in your free workspace.

  • 2 solicitation documentsRead every page
  • AI contract breakdown13 sections, Uniform Contract Format
  • Buyer contactEmail and phone
Open the full contract

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

Full Description

Show more
SUNY Downstate Health Sciences University (“SUNY DHSU”) intends to procure a not to exceed three (3) year agreement for Orthobiologic Products using Vizient Consortia Contract # MS9985 pursuant to its authority under New York State Finance Law, section 163(3)(vi) which authorizes the use of a consortium or comparable entity in lieu of using a centralized contract and without a formal competitive process when justified by price. Vendors who sell equivalent and compatible consumables may, if interested, contact the agent in the Purchasing Department, listed below, to discuss this procurement. Equivalency and compatibility must be demonstrated by meeting the performance of, and being compatible and interchangeable with existing equipment, supplies and accessories. Business enterprises awarded an identical or substantially similar procurement contract within the past five years: LifeNet Health Service-Disabled Veteran-Owned Business (SDVOB) SDVOB Goal: 0.00% Minority / Women Business Enterprise contracting goals (MWBE) MBE Goal: 0.00% WBE Goal: 0.00% Disadvantaged Business Enterprise contracting goals (DBE) DBE Goal: 0.00%

Similar Contracts

Same NAICS industry code

NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute (NCI) has issued a Notice of Funding Opportunity (RFA-CA-28-004) for a limited competition to support the continuation of two critical biospecimen banking resources: the National Clinical Trials Network (NCTN) Biobanks and the Early-Phase and Experimental Clinical Trials (EET) Biobank. The primary objective is to maintain national resources for the collection, processing, storage, and distribution of clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the investigation of drug response and resistance mechanisms. The NCI intends to fund approximately six awards with a total program funding of $19 million for fiscal year 2027, with a maximum direct cost limit of $3.0 million per year and a requested project period of six years. Applications are evaluated based on scientific and technical merit through the NIH peer-review system, focusing on significance, environment, and the likelihood of the project to exert a sustained influence on the research field. Eligible organizations must maintain active SAM and eRA Commons registrations and provide specific documentation, including the current scale of operation, accomplishments, and standard operating procedures. Awardees are required to implement robust quality assurance programs, adhere to Federal Human Subjects Regulations under 45 CFR 46, and follow strict cybersecurity incident reporting protocols, including notifying the HHS within 48 hours of discovery. There is no set-aside status specified for this opportunity.
National Institutes Of Health

POSTED

about 1 month ago

DEADLINE

in 3 months
View Details
NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.
National Cancer Institute

POSTED

about 1 month ago

DEADLINE

in 3 months
View Details
NAICS: 621991
SLED
Mobile Health Unit OperationsThe contract titled Mobile Health Unit Operations seeks a subcontractor to manage the operation and maintenance of mobile units tasked with delivering vision, dental, and hearing services to underserved communities across the region. These mobile units will serve as critical access points for essential health care, ensuring that populations with limited transportation or geographic barriers receive timely and consistent medical attention. The work involves the full lifecycle management of the units, including routine maintenance, repairs, staffing coordination, logistics, and compliance with health and safety standards to guarantee reliable service delivery. The contract is categorized as a subcontract under NAICS code 621991 and is solicited by the Houston-Galveston Area Council through the Texas SmartBuy platform. The solicitation was posted on July 22, 2026, with a response deadline of July 29, 2027, providing over a year for prospective vendors to prepare proposals. The place of performance spans the region served by the council, though exact locations are not specified, indicating flexibility in service deployment based on community need. While details on set-aside status and point of contact are unavailable, the focus remains on operational excellence and equitable access to preventive and diagnostic health services in areas lacking permanent clinical infrastructure.
HOUSTON-GALVESTON AREA COUNCIL

POSTED

4 months ago

DEADLINE

in 8 months
View Details

More opportunities from State University of New York (SUNY)

Same awarding agency

Get AI-powered intelligence on this solicitation and the ones like it

Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.

Miguel
Hillary
Keith Deutsch
Christine

Join 900+ contractors already using CLEATUS